Biopharmaceutical company UCB (EBR:UCB) announced on Monday the launch of the inaugural UCB Hidradenitis Suppurativa Scholarship Program.

This program is designed to support adults age 18 and older living with hidradenitis suppurativa (HS), and their immediate family members, in pursuing education and career development.

Applications for the inaugural HS scholarship program are open at www.ucbhsscholarship.com through September 1, 2026. UCB will award up to 11 scholarships in 2026.

The UCB Hidradenitis Suppurativa Scholarship Program aims to help ease the financial burden associated with education and skills development, including undergraduate or graduate studies, certification programs, trade school, and other career-building pathways.

HS is a chronic, painful, and potentially debilitating inflammatory skin disease with symptoms including nodules, abscesses, and pus-discharging draining tunnels (or sinus tracts leading out of the skin) which typically occur in the armpits, groin, and buttocks.